摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)-3-[2-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-en-1-one | 1322776-34-0

中文名称
——
中文别名
——
英文名称
(E)-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)-3-[2-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-en-1-one
英文别名
(E)-1-[4-[[4-[2-(4-chlorophenoxy)ethyl]phenyl]methyl]piperazin-1-yl]-3-[2-methyl-4-[5-[(4-methylphenyl)methoxy]pyridin-2-yl]oxyphenyl]prop-2-en-1-one
(E)-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)-3-[2-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-en-1-one化学式
CAS
1322776-34-0
化学式
C42H42ClN3O4
mdl
——
分子量
688.266
InChiKey
USGAMGUHRCUAFM-UDWIEESQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.7
  • 重原子数:
    50
  • 可旋转键数:
    13
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    64.1
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS
    申请人:Takasu Hideki
    公开号:US20120283242A1
    公开(公告)日:2012-11-08
    The present invention provides a novel compound having an excellent antitumor effect. The compound of the present invention is represented by the following general formula (1) wherein R 1 and R 2 are aryl or the like; A is lower alkylene; Ring X is optionally substituted arylene; E is bond or lower alkenylene; Ring Y is optionally substituted heterocycloalkylene containing one or more nitrogen atoms, one of which is attached to the adjacent carbonyl group; G is —NH-G 2 -, —N(lower alkyl)-G 2 -, —NH—CH 2 -G 2 -, —N(lower alkyl)-CH 2 -G 2 - or —CH 2 -G 2 -, [wherein G 2 binds to R 2 , G 2 -R 2 is bond-R 2 , phenylene-G 3 -R 2 , phenylene-G 4 -O—R 2 , phenylene-G 5 -NH—R 2 , phenylene-G 6 -N(lower alkyl)-R 2 or quinolinediyl-O—R 2 , the phenylene of said phenylene-containing groups being optionally substituted with one or more substituents; G 3 -R 2 is —O-lower alkylene-R 2 or the like; G 4 -O— is lower alkylene-O— or the like; G 5 is lower alkylene; G 6 is lower alkylene].
    本发明提供了一种具有优异抗肿瘤效果的新型化合物。本发明的化合物由下述通式(1)表示,其中R1和R2为芳基或类似物;A为低级烷基;环X为可选取代的芳基;E为键或低级基;环Y为可选取代的杂环烷基,其中一个原子连接到相邻的羰基;G为—NH-G2-,—N(低级烷基)-G2-,—NH—CH2-G2-,—N(低级烷基)- -G2-或— -G2-,[其中G2与R2相连,G2-R2为键-R2,基-G3-R2,基-G4-O—R2,基-G5-NH—R2,基-G6-N(低级烷基)-R2或喹啉基-O—R2,所述基含有的基-含基团可选取代一个或多个取代基;G3-R2为—O-低级烷基-R2或类似物;G4-O—为低级烷基-O—或类似物;G5为低级烷基;G6为低级烷基]。
  • DI-SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS
    申请人:Otsuka Pharmaceutical Co., Ltd.
    公开号:EP2528897B1
    公开(公告)日:2014-10-15
  • US8722663B2
    申请人:——
    公开号:US8722663B2
    公开(公告)日:2014-05-13
查看更多